GMP Synthase Antikörper (AA 301-400) (Biotin)
Kurzübersicht für GMP Synthase Antikörper (AA 301-400) (Biotin) (ABIN1700317)
Target
Alle GMP Synthase (GMPS) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 301-400
-
Homologie
- Human,Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human GMP Synthase
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- GMP Synthase (GMPS) (Guanine Monophosphate Synthetase (GMPS))
-
Andere Bezeichnung
- GMP Synthase
-
Hintergrund
-
Synonyms: GMPS, Glutamine amidotransferase, GMP synthase [glutamine hydrolyzing], GMP synthase [glutamine-hydrolyzing], GMP synthetase, Gmps, GUAA_HUMAN, Guanine monphosphate synthetase, MLL/GMPS fusion protein.
Background: In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP. [provided by RefSeq, Jul 2008].
-
Gen-ID
- 8833
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-